We are happy to announce that a new research project entitled ‘Design and synthesis of chimeric recombinant surface proteins of the SARS-CoV-2 virus to produce a vaccine in yeasts’ (IN845D 2020/05) has been launched recently. The project is funded by the Galician Innovation Agency and leaded by Dr J. M. Leiro and Dr M.I. González Siso. University of Santiago de Compostela and University of A Coruña from Spain will collaborate to accomplish the project. The project proposal is based on the biosynthesis of chimeric recombinant proteins, formed by peptides obtained from surface proteins of SARS-CoV-2 and to be used as vaccines, in a GRAS yeast expression system. Thus, it is strongly connected with Yeast4Bio Cost Action in respect of its aims and partners.

 

Congratulation for the very interesting research project and new collaborations!